Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Complex regional pain syndrome (CRPS) is a painful, disabling, chronic condition whose etiology remains poorly understood. The recent suggestion that immunological mechanisms may underlie CRPS provides an entirely novel framework in which to study the condition and consider new approaches to treatment. Using a murine fracture/cast model of CRPS, we studied the effects of B-cell depletion using anti-CD20 antibodies or by performing experiments in genetically B-cell-deficient (μMT) mice. We observed that mice treated with anti-CD20 developed attenuated vascular and nociceptive CRPS-like changes after tibial fracture and 3 weeks of cast immobilization. In mice with established CRPS-like changes, the depletion of CD-20+ cells slowly reversed nociceptive sensitization. Correspondingly, μMT mice, deficient in producing immunoglobulin M (IgM), failed to fully develop CRPS-like changes after fracture and casting. Depletion of CD20+ cells had no detectable effects on nociceptive sensitization in a model of postoperative incisional pain, however. Immunohistochemical experiments showed that CD20+ cells accumulate near the healing fracture but few such cells collect in skin or sciatic nerves. On the other hand, IgM-containing immune complexes were deposited in skin and sciatic nerve after fracture in wild-type, but not in μMT fracture/cast, mice. Additional experiments demonstrated that complement system activation and deposition of membrane attack complexes were partially blocked by anti-CD20+ treatment. Collectively, our results suggest that CD20-positive B cells produce antibodies that ultimately support the CRPS-like changes in the murine fracture/cast model. Therapies directed at reducing B-cell activity may be of use in treating patients with CRPS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Natural History of Complex Regional Pain Syndrome
Schwartzman, R. J., Erwin, K. L., & Alexander, G. M. (2009) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31818ecea5 · Cited by 191 · cited 1×
“However, CRPS present for a period of 1 year or greater seldom spontaneously resolves [55], and worsens in most patients from years 1 to 8 after onset [65].”
BackgroundThe Outcome of Complex Regional Pain Syndrome Type 1: A Systematic Review
Bean, D. J., Johnson, M. H., & Kydd, R. R. (2014) · The Journal of Pain · doi:10.1016/j.jpain.2014.01.500 · Cited by 137 · cited 1×
“Acute CRPS often improves over the first year, particularly if therapy is initiated early in the course of the condition [1].”
BackgroundGuillain-Barré syndrome and anti-ganglioside antibodies: A clinician-scientist’s journey
YUKI, N. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.299 · Cited by 109
Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations
Koike, H., Tanaka, F., & Sobue, G. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834a87b7 · Cited by 105 · cited 1×
“In the case of paraneoplastic neuropathies, autoimmunity involving anti-Hu and anti-CV2/CRIMP5 antibodies have been linked to sensory changes involving pain [31].”
Background
Cited by
Complex regional pain syndrome
Bruehl, S. (2015) · BMJ · doi:10.1136/bmj.h2730 · Cited by 362
Passive transfer of fibromyalgia symptoms from patients to mice
Goebel, A., Krock, E., Gentry, C., Israel, M. R., Jurczak, A., Urbina, C. M., Sandor, K., Vastani, N., Maurer, M., Cuhadar, U., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144201 · Cited by 278
“These observations, together with the markedly increased prevalence of FMS among patients with autoimmune rheumatological conditions (9, 10), and demonstrations that less common (26, 27) and very rare chronic pains (28) are caused by autoantibodies, led us to hypothesize that FMS may have an autoimmune basis.”
BackgroundYavne, Y., Amital, D., Watad, A., Tiosano, S., & Amital, H. (2018) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.12.011 · Cited by 99
Krock, E., Morado-Urbina, C. E., Menezes, J., Hunt, M. A., Sandström, A., Kadetoff, D., Tour, J., Verma, V., Kultima, K., Haglund, L., et al. (2023) · Pain · doi:10.1097/j.pain.0000000000002881 · Cited by 84
“other nociplastic pain conditions like complex regional pain syndrome.(11,18,30) We found that transferring FM IgG into mice”
BackgroundAutoantibodies produce pain in complex regional pain syndrome by sensitizing nociceptors
Cuhadar, U., Gentry, C., Vastani, N., Sensi, S., Bevan, S., Goebel, A., & Andersson, D. A. (2019) · Pain · doi:10.1097/j.pain.0000000000001662 · Cited by 74
Metadata
- Authors
- Li, W.-W., Guo, T.-Z., Shi, X., Czirr, E., Stan, T., Sahbaie, P., Wyss-Coray, T., Kingery, W. S., & Clark, D. J.
- Venue
- Pain
- Published
- 2014-11
- Volume
- 155
- Issue
- 11
- Pages
- 2377-2389
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2026172180
- Cited by
- 94
- References
- 4
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome. https://app.cochat.ai/papers/10.1016/j.pain.2014.09.007
- The paper
- Li, W.-W., Guo, T.-Z., Shi, X., Czirr, E., Stan, T., Sahbaie, P., Wyss-Coray, T., Kingery, W. S., & Clark, D. J. (2014). Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome. Pain. https://doi.org/10.1016/j.pain.2014.09.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.